RxDoctor Payments Data

Marina Garrison, APRN

Family · Lawton, OKNPI 1902207798

Payments from drug & device makers

$3,819in general payments, 2019–2025

Across 181 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$366
  • Takeda Pharmaceuticals U.S.A., Inc.$304
  • Novartis$217
  • Incyte Corporation$210
  • Sanofi$204
  • AbbVie$193
  • plus $2K from 44 others

What the payments were for

  • Food & beverage$3,806100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,819 in reported general payments places this provider in the 90th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$44,529
Medicare patients
576
Services billed
1,943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil142$8,939
Imiquimod12$262
Mupirocin19$239
Cephalexin24$56

Paid to pharmacies, not to this prescriber.

Other family in Lawton

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →